Insider Selling: BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Director Sells 4,689 Shares of Stock
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Free Report) Director Machelle Sanders sold 4,689 shares of the business’s stock in a transaction on Monday, June 17th. The stock was sold at an average price of $6.00, for a total value of $28,134.00. Following the completion of the transaction, the director now directly owns 27,742 shares in […]
More Stories
Weather, Power, and Water Issues Persist in Los Angeles’ Eaton Fire Area
By Beige Luciano-Adams LOS ANGELES—Residents eager to return home and survey vast damage wrought by the Eaton Canyon Fire in...
Titanium Transportation Group (CVE:TTR) Share Price Passes Below 50 Day Moving Average – Should You Sell?
Titanium Transportation Group Inc. (CVE:TTR – Get Free Report)’s share price passed below its 50 day moving average during trading...
Invesco Aerospace & Defense ETF (NYSEARCA:PPA) Stock Price Passes Below 50-Day Moving Average – Here’s Why
Invesco Aerospace & Defense ETF (NYSEARCA:PPA – Get Free Report) shares crossed below its fifty day moving average during trading...
ImmuPharma (LON:IMM) Shares Up 4.9% – What’s Next?
ImmuPharma plc (LON:IMM – Get Free Report)’s share price shot up 4.9% during mid-day trading on Saturday . The company...
Omineca Mining and Metals (CVE:OMM) Stock Price Down 15.4% – Here’s Why
Omineca Mining and Metals Ltd. (CVE:OMM – Get Free Report)’s stock price traded down 15.4% on Saturday . The company...
China Shenhua Energy (OTCMKTS:CSUAY) Stock Passes Below 50 Day Moving Average – Here’s What Happened
Shares of China Shenhua Energy Company Limited (OTCMKTS:CSUAY – Get Free Report) passed below its 50 day moving average during...